ERBITUX(R) Approved for First-line Use in China in Patients W...
DARMSTADT, Germany, Mar. 2, 2020 /PRNewswire-AsiaNet/-- Not intended for UK-based media- Approval is for ERBITUX(R) in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHN- Pivotal Phase III study shows significant improvements with ERBITUX(R) in c...
Authors: LATEST ASIANET NEWS RELEASES